US Stock MarketDetailed Quotes

ADXS Ayala Pharmaceuticals

Watchlist
  • 0.030000
  • +0.003000+11.11%
15min DelayClose Jan 8 16:00 ET
1.28MMarket Cap0.00P/E (TTM)

About Ayala Pharmaceuticals Company

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company was founded on June 5, 1987 and is headquartered in Monmouth Junction, NJ.

Company Profile

SymbolADXS
Company NameAyala Pharmaceuticals
Founded1987
CEOMr. Kenneth A. Berlin
MarketPink Market
Employees21
Fiscal Year Ends12-31
Address9 Deer Park Drive,Suite K-1
CityMonmouth Junction
ProvinceNew Jersey
CountryUnited States of America
Zip Code08852
Phone1-609-452-9813
Websitehttp://www.ayalapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Anthony A. Lombardo
  • Interim Chief Executive Officer
  • --
  • Sara Bonstein
  • Chief Financial Officer, Executive Vice President and Corporate Secretary
  • --
  • Robert Petit, PhD
  • Chief Scientific Officer and Executive Vice President
  • --
  • Clay Siegall
  • Chairman and Director
  • --
  • Dr. James Patton
  • Vice Chairman of the Board
  • --
  • Dr. David Sidransky, M.D.
  • Chairman of the Board
  • --
  • Philip Wagenheim
  • Director
  • --
  • James Boylan
  • Director
  • --
  • Carol A. Schafer
  • Director
  • --
  • Sandra M. Swain
  • Director
  • --
  • Jean-Jacques Bienaime
  • Director
  • --
  • Dr. Thomas Mckearn, PhD
  • Independent Director
  • --
  • Dr. Samir N. Khleif
  • Independent Director
  • --
  • Isaac Barchas
  • Lead Independent Director
  • --
  • The Honourable Tom Ridge
  • Independent Director
  • --
  • Roni A. Appel
  • Independent Director
  • --
  • Richard J. Berman
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-7.05%